-+ 0.00%
-+ 0.00%
-+ 0.00%

Is BWX Technologies (BWXT) Still Undervalued As New DOE And Army Wins Test Its Valuation?

Simply Wall St·09/06/2026 04:24:03
語音播報

BWX Technologies (BWXT) is back in focus after two fresh government related wins. The company secured a U.S. Department of Energy contract for lithium processing design work and was chosen to deploy its BWXT Advanced Nuclear Reactor with the U.S. Army’s Janus program.

These contract wins come after a mixed stretch for the BWX Technologies share price, which is around $157.59 and has fallen 7.25% over the past month and 15.93% over the past 90 days, even as the 3 year total shareholder return of 123.95% and 5 year total shareholder return of 194.67% point to strong long term compounding. Recent analyst coverage and the Janus and lithium processing announcements appear to be testing whether that earlier momentum can resume or whether investors see higher execution risk being priced into the stock.

Scan other nuclear infrastructure stocks that could be seeing similar interest by reviewing our hand picked 91 nuclear energy infrastructure stocks alongside BWX Technologies after these contract announcements.

BWX Technologies now sits at an interesting crossroads. After a sharp pullback and fresh contract wins, is most of the stock’s value story already in the rearview mirror, or is there still clear upside left on the table as you weigh valuation next?

Most Popular Narrative: 32.2% Undervalued

BWX Technologies is trading at $157.59 while the most followed narrative anchors fair value closer to $232.31, which sets a high bar for the contract wins investors are watching now.

Record $6 billion backlog (+70% YoY) and 23% quarter-over-quarter growth, driven by multi-year defense contracts, rapidly expanding opportunity pipeline, and accelerating nuclear energy/medical demand signal strong visibility into future revenue growth and earnings stability.

Read the complete narrative. Read the complete narrative.

Investors may be curious what has to happen in BWX Technologies' income statement to support that higher fair value. The narrative refers to compound revenue growth, firmer margins and a richer profit multiple than the broader Aerospace & Defense group. Readers may want to see exactly how those elements fit together and which future earnings line the valuation relies on most.

Result: Fair Value of $232.31 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, BWX Technologies still faces meaningful swing factors, including its heavy reliance on long term U.S. government contracts and ongoing margin pressure in commercial operations.

Find out about the key risks to this BWX Technologies narrative.

Another View on BWX Technologies Valuation

The most followed BWX Technologies narrative leans on a fair value of $232.31, yet the current P/E ratio of 40.7x tells a different story. That multiple is higher than the US Aerospace & Defense average of 37x, the peer average of 23.3x, and a fair ratio estimate of 26.4x. This gap points to richer expectations baked into the price and raises the question of how much upside is left if those expectations are already ambitious.

For a closer look at how these valuation signals line up with the company’s fundamentals, check out the detailed breakdown in our valuation workup, which digs into how the current price compares to that fair ratio benchmark. See what the numbers say about this price — find out in our valuation breakdown.

NYSE:BWXT P/E Ratio as at Sep 2026
NYSE:BWXT P/E Ratio as at Sep 2026

Next Steps

Given the mix of enthusiasm and caution around BWX Technologies in this article, it makes sense to act promptly and weigh the full picture yourself by reviewing the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond BWX Technologies?

If you are serious about building a stronger portfolio, do not stop at BWX Technologies. Use targeted stock ideas to pressure test and upgrade your next moves.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.